Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | -1.96% | -11.50% | -37.89% |
Sales 2024 * | 30.47M 2.44B | Sales 2025 * | 71.52M 5.73B | Capitalization | 1.06B 85.15B |
---|---|---|---|---|---|
Net income 2024 * | -174M -13.93B | Net income 2025 * | -127M -10.17B | EV / Sales 2024 * | 12.7 x |
Net cash position 2024 * | 678M 54.25B | Net cash position 2025 * | 585M 46.84B | EV / Sales 2025 * | 6.69 x |
P/E ratio 2024 * |
-5.06
x | P/E ratio 2025 * |
-7.63
x | Employees | 467 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 3.32% |
Latest transcript on Autolus Therapeutics plc
1 day | -1.96% | ||
1 week | -11.50% | ||
Current month | -37.30% | ||
1 month | -35.17% | ||
3 months | -32.66% | ||
6 months | +48.70% | ||
Current year | -37.89% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Pulé
FOU | Founder | 51 | 31/08/14 |
Chief Executive Officer | 59 | 30/09/14 | |
Robert Dolski
DFI | Director of Finance/CFO | 54 | 06/08/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Berriman
BRD | Director/Board Member | 76 | 31/07/14 |
William Young
BRD | Director/Board Member | 79 | 14/11/21 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 28/02/18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 4 | -1.96% | 2,745,490 |
25/04/24 | 4.08 | -3.09% | 3,872,988 |
24/04/24 | 4.21 | -6.03% | 2,720,848 |
23/04/24 | 4.48 | -1.75% | 1,723,804 |
22/04/24 | 4.56 | +0.88% | 1,154,024 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.89% | 1.06B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AUTL Stock